IOCBTech is a technology transfer office and subsidiary company of IOCB (the Institute of Organic Chemistry and Biochemistry CAS). The company matches results of basic research done at the IOCB with needs of commercial partners to ultimately bring new ideas in medicinal chemistry, material sciences, and other fields of chemistry to human use.
Projects & Opportunities
Here you can explore our projects which are available for co-development or licensings.
About IOCB Tech
The IOCB Tech team supports management and decision-making processes in Target Research Groups of IOCB e.g. by due diligence analyses, market potential studies, and project feasibility evaluation. Moreover, the company is responsible for networking and industry partner search or negotiations of contracts and agreements in the field of intellectual property.
An integral part of IOCB Tech’s duties is the organization and development of spin-off companies on IOCB’s technology platform.
Czech science will be supported by tens of millions of crowns from the new endowment fund.
Young Czech Scientists Head to Israel Thanks to New Scientific Internship Project
Neuron Endowment Fund and IOCB Tech decide to provide financial support to Ukrainian scientists
Czech science to receive hundreds of millions of CZK from IOCB Tech
New Coronavirus Protective Antibody Test License to Immunotech, a Subsidiary of Beckman Coulter.
The First Commercial sales of Lu-177
IOCB Tech donates kits for 10,000 COVID-19 tests to Public Health Institute Ostrava
MediAim – new therapeutic and drug development strategies
viral RNA isolation kits developed at IOCB and RCPTM
IOCB enters partnership with Neuron Endowment Fund
IOCB Tech donates 7 million CZK to fight coronavirus
SHINE and IOCB Prague deliver Lu-177 dose to GE Healthcare, advance therapeutic isotope
Happy New Year 2020
UCT and IOCB Prague establish special research chair